12 July 2022>: Database Analysis
LINC00963 May Be Associated with a Poor Prognosis in Patients with Cervical Cancer
Aimin Chang ACDEFG* , Ying Shi BCDE , Ping Wang BCD , Jingjing Ren BCFDOI: 10.12659/MSM.935070
Med Sci Monit 2022; 28:e935070
Table 2 LINC00963 expression associated with clinicopathologic characteristics (logistic regression).
Characteristics | Odds Ratio in LINC00963 expression | Odds ratio (OR) | P value |
---|---|---|---|
T stage (T2 & T3 & T4 vs T1) | 241 | 0.66 (0.40–1.11) | 0.120 |
N stage (N1 vs N0) | 193 | 2.36 (1.26–4.52) | 0.008 |
M stage (M1 vs M0) | 126 | 0.46 (0.10–1.74) | 0.276 |
Clinical stage (Stage II & Stage III & Stage IV vs Stage I) | 297 | 0.71 (0.45–1.13) | 0.150 |
Primary therapy outcome (CR vs PD & SD &PR) | 217 | 2.23 (1.08–4.80) | 0.033 |
Histological type (squamous cell carcinoma vs adenosquamous) | 304 | 0.16 (0.07–0.33) | |
Histologic grade (G3 & G4 vs G1 & G2) | 272 | 1.04 (0.64–1.68) | 0.879 |
PIK3CA status (Mut vs WT) | 286 | 1.28 (0.76–2.14) | 0.350 |